Shares of Myriad Genetics ( MYGN -7.7% ) trade sharply lower out of the gate on the heels of a ..... an error, there is unlikely to be a fix in place by January 1." MYGN downgraded to Market Perform. Post your comment!
Shares of Myriad Genetics fell in trading Monday after one of its patent litigation targets, Invitae Corporation, announced that it is countersuing Myriad
XOMA +15% . WPCS +13% . EVK +15% . GOGO +13% . MEIL +12% . Top 10 Losers: ZOOM -26% . IR -21% . RFIL -20% . CIE -16% . MBIS -11% . OPHC -12% . MHH -12% . MYGN -11% . MCOX -11% . ASTM -11% . Post your comment!
McGrath : Love it or hate it, Myriad Genetics Inc. ( MYGN ) has afforded both those long ..... low of $22.77 on Oct. 11. MYGN closed on Friday at $28.79 ..... the biotechnology industry, and MYGN in particular indicate investors
Nov 20 (Reuters) - Myriad Genetics Inc : * Announces second hrd collaboration * Says research collaboration with Biomarin that will use Myriad's novel hrd
"We maintain our Neutral rating as we believe Myriad Genetics ( MYGN +1% ) is unlikely to get full credit for the FQ1 ..... pressures," Goldman says, summing up the outlook for MYGN nicely. The company blew away estimates and lifted
Myriad Genetics reported first-quarter results on Tuesday that exceeded our forecast on the strength of BRACAnalysis’ performance. Management
Top 10 Gainers: MSPD +69% . MCHX +22% . REGI +14% . BCOR +12% . OXBT +10% . AXAS +10% . MYGN +9% . YRCW +7% . VRNG +7% . ANV +7% . AU +6% . ABIO +6% . Z +6% . OPEN +5% . RMTI +5% . NQ +5% . ECOM +5
Myriad Genetics ( MYGN ) blows away Street estimates for FQ1 as revenue rises 52% Y/Y to $202.5M and net ..... guidance of $690-710M). Consensus is $1.90/share on $692.3M in sales. ( PR ) MYGN +5.2% AH Post your comment!
Myriad Genetics ( MYGN ): FQ1 EPS of $0.68 beats by $0.22 . Revenue of $202.5M (+52% Y/Y) beats by $34.86M . ( PR ) Post your comment!